“Our goal is to cure the cancer as effectively as we can while using as few treatments as possible,” said Ramesh Rengan, assistant professor at University of Pennsylvania in Philadelphia.
“This study is so exciting because it demonstrates that giving patients with head and neck cancer a non-invasive regimen of cisplatin-based chemotherapy and radiation therapy effectively treats many advanced head and neck cancers, meaning some patients can safely avoid an invasive surgery.”
A standard of care for patients with advanced head and neck cancer is chemotherapy and radiation followed by surgery to the neck. This study instead focused on treating the patients with chemotherapy and radiation and then measuring the patients’ response to see if they still needed the follow-up neck surgery.
80% percent of the patients with advanced head and neck cancer who participated in this study had a complete response to chemoradiation alone with elimination of any detectable disease in the neck. Of these patients who achieved eradication of neck disease, 85% were able to maintain long-term remission without the need for additional invasive neck surgery.